Stock Price Prediction

GNFT stock is currently trading at $3.77, with a recent decline of 6.05% in regular trading. Bullish analysts highlight its strong financial turnaround, including $61.1M in quarterly revenue and $30.31M net profit, alongside a "Moderate Buy" consensus and an average price target of $9.01, indicating significant upside potential. Kepler Capital's €8.40 target further supports optimism, driven by its focus on high unmet medical needs in biopharmaceuticals.

GNFT stock is bearish, closing at $3.73 on January 31, 2025, with a 6.05% drop in regular trading and a pre-market decline of 4.28%. The recent sell-off reflects weak market sentiment despite improved financials, as quarterly revenue rose to $61.1M with a $30.31M net profit. However, the stock's inability to sustain gains and its current price below analyst targets ($8.82 average) signals limited short-term upside.